Protagonist Therapeutics (NASDAQ:PTGX) reported quarterly losses of $(0.64) per share. This is a 8.57 percent increase over losses of $(0.70) per share from the same period last year.
Amazon.com To $170? Plus This Analyst Lowers Price Target On Meta Platforms
Credit Suisse cut the price target for Amazon.com, Inc. (NASDAQ: AMZN) from $185 to $170. However, Credit Suisse analyst Stephen Ju maintained the stock with an Outperform rating. Amazon shares fell 4.1% to $116.17 in pre-market trading.
